Cancer Stem Cells in Prostate Cancer Chemoresistance
Journal:
Current Cancer Drug Targets
Volume:
14
Page:
225-240
Author(s):
Jie Ni, Paul Cozzi, Jingli Hao, Wei Duan, Peter Graham, John Kearsley and Yong Li
Is the Clinical Use of Cannabis by Oncology Patients Advisable?
Journal:
Current Medicinal Chemistry
Volume:
21
Page:
1923-1930
Author(s):
Gil Bar-Sela, Adva Avisar, Ron Batash and Moshe Schaffer
Novel Insights Into the Role of MicroRNA in Lung Cancer Resistance to Treatment and Targeted Therapy
Journal:
Current Cancer Drug Targets
Volume:
14
Page:
241-258
Author(s):
Zhaohui Gong, Jie Yang, Jingqiu Li, Lihua Yang, Yanping Le, Shaomin Wang and Hui-Kuan Lin
Gene Delivery for Cancer Therapy
Journal:
Current Drug Delivery
Volume:
11
Page:
233-242
Author(s):
Teng Zhang
Need to Think Outside Organ-based Diagnosis to Molecular Diagnostics
Journal:
Applied Clinical Research, Clinical Trials and Regulatory Affairs
Volume:
1
Page:
10-12
Author(s):
Alia Albawardi
Current View on the Mechanism of Action of Perifosine in Cancer
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
14
Page:
629-635
Author(s):
Joachim Fensterle, Babette Aicher, Irene Seipelt, Michael Teifel and Juergen Engel
The Proteolytic Activation of Angiogenic and Lymphangiogenic Growth Factors in Cancer – Its Potential Relevance for Therapeutics and Diagnostics
Journal:
Current Medicinal Chemistry
Volume:
21
Page:
1821-1842
Author(s):
Nicole C. Harris and Marc G. Achen
[6]-gingerol as a Cancer Chemopreventive Agent: A Review of Its Activity on Different Steps of the Metastatic Process
Journal:
Mini-Reviews in Medicinal Chemistry
Volume:
14
Page:
313-321
Author(s):
Juliana Poltronieri, Amanda B. Becceneri, Angelina M. Fuzer, Julio Cesar C. Filho, Ana Carolina B.M. Martin, Paulo Cezar Vieira, Normand Pouliot and Márcia R. Cominetti
Plant Glycosides and Aglycones Displaying Antiproliferative and Antitumour Activities – A Review
Journal:
Current Bioactive Compounds
Volume:
9
Page:
288-305
Author(s):
Aenakshi Shah, Chitra Varma, Sandeep Patankar and Vilasrao Kadam
A Family of Pleiotropically Acting MicroRNAs in Cancer Progression, miR-200: Potential Cancer Therapeutic Targets
Journal:
Current Pharmaceutical Design
Volume:
20
Page:
1896-1903
Author(s):
Hai-Feng Zhang, Li-Yan Xu and En-Min Li